Mergers & acquisitions
The company struck the cash-and-share deals to boost its presence in Europe.
News of the buy was tucked away in the company’s fourth-quarter financial report.
This acquisition strategy is part of its two-pronged approach to growth, along with internal R&D.
Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved.
Here are five possible acquisition targets to keep an eye on.
Employees of Juno received a surprise in their Monday morning emails.
The latest acquisition makes it the highest amount paid for a flex R&D building in Los Angeles County.
The year is already off to a good start with mergers and acquisitions in the biopharma industry.
Sinocare of Changsha may bid as much as $4B to acquire J&J’s diabetes medical device subsidiaries
Most investors and analysts are expecting 2018 to be a big year for mergers and acquisitions.
PRESS RELEASES